Zobrazeno 1 - 10
of 2 558
pro vyhledávání: '"Punnonen, J."'
Autor:
McKenzie, A. N. J., Culpepper, J. A., Briere, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B. G., Menon, S., De Vries, J. E., Banchereau, J., Zurawski, G.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1993 Apr . 90(8), 3735-3739.
Externí odkaz:
https://www.jstor.org/stable/2361820
Autor:
Zúñiga LA; Ascendis Pharma, Inc., Redwood City, CA, USA., Leßmann T; Ascendis Pharma GmbH, Heidelberg, Germany., Uppal K; Ascendis Pharma, Inc., Redwood City, CA, USA., Bisek N; Ascendis Pharma GmbH, Heidelberg, Germany., Hong E; Ascendis Pharma, Inc., Redwood City, CA, USA., Rasmussen CE; Ascendis Pharma A/S, Hellerup, Copenhagen, Denmark., Karlsson JJ; Ascendis Pharma A/S, Hellerup, Copenhagen, Denmark., Zettler J; Ascendis Pharma GmbH, Heidelberg, Germany., Holten-Andersen L; Ascendis Pharma A/S, Hellerup, Copenhagen, Denmark., Bang K; Ascendis Pharma, Inc., Redwood City, CA, USA., Thakar D; Ascendis Pharma, Inc., Redwood City, CA, USA., Lee YC; Ascendis Pharma, Inc., Redwood City, CA, USA., Martinez S; Ascendis Pharma, Inc., Redwood City, CA, USA., Sabharwal SS; Ascendis Pharma, Inc., Redwood City, CA, USA., Stark S; Ascendis Pharma GmbH, Heidelberg, Germany., Faltinger F; Ascendis Pharma GmbH, Heidelberg, Germany., Kracker O; Ascendis Pharma GmbH, Heidelberg, Germany., Weisbrod S; Ascendis Pharma GmbH, Heidelberg, Germany., Müller R; Ascendis Pharma GmbH, Heidelberg, Germany., Voigt T; Ascendis Pharma GmbH, Heidelberg, Germany., Bigott K; Ascendis Pharma GmbH, Heidelberg, Germany., Tabrizifard M; Ascendis Pharma, Inc., Redwood City, CA, USA., Breinholt VM; Ascendis Pharma A/S, Hellerup, Copenhagen, Denmark., Mirza AM; Ascendis Pharma, Inc., Redwood City, CA, USA., Rosen DB; Ascendis Pharma, Inc., Redwood City, CA, USA., Sprogøe K; Ascendis Pharma A/S, Hellerup, Copenhagen, Denmark. ks@ascendispharma.com., Punnonen J; Ascendis Pharma, Inc., Redwood City, CA, USA.
Publikováno v:
Cancer cell international [Cancer Cell Int] 2022 Sep 19; Vol. 22 (1), pp. 286. Date of Electronic Publication: 2022 Sep 19.
Autor:
Rosen DB; Ascendis Pharma Inc, Redwood City, California, USA drn@ascendispharma.com., Kvarnhammar AM; Ascendis Pharma A/S, Hellerup, Denmark., Laufer B; Ascendis Pharma GmbH, Heidelberg, Germany., Knappe T; Ascendis Pharma GmbH, Heidelberg, Germany., Karlsson JJ; Ascendis Pharma A/S, Hellerup, Denmark., Hong E; Ascendis Pharma Inc, Redwood City, California, USA., Lee YC; Ascendis Pharma Inc, Redwood City, California, USA., Thakar D; Ascendis Pharma Inc, Redwood City, California, USA., Zúñiga LA; Ascendis Pharma Inc, Redwood City, California, USA., Bang K; Ascendis Pharma Inc, Redwood City, California, USA., Sabharwal SS; Ascendis Pharma Inc, Redwood City, California, USA., Uppal K; Ascendis Pharma Inc, Redwood City, California, USA., Olling JD; Ascendis Pharma A/S, Hellerup, Denmark., Kjaergaard K; Ascendis Pharma A/S, Hellerup, Denmark., Kurpiers T; Ascendis Pharma GmbH, Heidelberg, Germany., Schnabel M; Ascendis Pharma GmbH, Heidelberg, Germany., Reich D; Ascendis Pharma GmbH, Heidelberg, Germany., Glock P; Ascendis Pharma GmbH, Heidelberg, Germany., Zettler J; Ascendis Pharma GmbH, Heidelberg, Germany., Krusch M; Ascendis Pharma GmbH, Heidelberg, Germany., Bernhard A; Ascendis Pharma GmbH, Heidelberg, Germany., Heinig S; Ascendis Pharma GmbH, Heidelberg, Germany., Konjik V; Ascendis Pharma GmbH, Heidelberg, Germany., Wegge T; Ascendis Pharma GmbH, Heidelberg, Germany., Hehn Y; Ascendis Pharma GmbH, Heidelberg, Germany., Killian S; Ascendis Pharma GmbH, Heidelberg, Germany., Viet L; Ascendis Pharma GmbH, Heidelberg, Germany., Runz J; Ascendis Pharma GmbH, Heidelberg, Germany., Faltinger F; Ascendis Pharma GmbH, Heidelberg, Germany., Tabrizi M; Ascendis Pharma Inc, Redwood City, California, USA., Abel KL; Ascendis Pharma A/S, Hellerup, Denmark., Breinholt VM; Ascendis Pharma A/S, Hellerup, Denmark., Singel SM; Ascendis Pharma Inc, Palo Alto, California, USA., Sprogøe K; Ascendis Pharma A/S, Hellerup, Denmark., Punnonen J; Ascendis Pharma Inc, Redwood City, California, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).
Autor:
Punnonen, J.1
Publikováno v:
Clinical & Experimental Immunology. Mar1989, Vol. 75 Issue 3, p421-426. 6p.
Autor:
Galletta, Francesca1 (AUTHOR), Gambadauro, Antonella1 (AUTHOR), Foti Randazzese, Simone1 (AUTHOR) francygall.92@gmail.com, Passanisi, Stefano1 (AUTHOR) stefano.passanisi@unime.it, Sinatra, Vito1 (AUTHOR), Caminiti, Lucia1 (AUTHOR), Zirilli, Giuseppina1 (AUTHOR), Manti, Sara1 (AUTHOR) stefano.passanisi@unime.it
Publikováno v:
Life (2075-1729). Oct2024, Vol. 14 Issue 10, p1329. 20p.
Autor:
Pérez-Carranza, Gloria Aleida1 (AUTHOR) gloria.perez5249@alumnos.udg.mx, Godínez-Rubí, Juliana Marisol2,3 (AUTHOR) marisol.godinez@cucs.udg.mx, Márquez-Rosales, María Guadalupe4 (AUTHOR) qfb_lupita@hormail.com, Flores-Soto, Mario Eduardo4 (AUTHOR) mario.flore@imss.gob.mx, Bitzer-Quintero, Oscar Kurt4 (AUTHOR) oscar.bitzer@imss.gob.mx, Ramírez-Anguiano, Ana Cristina1 (AUTHOR) ana.ranguiano@academicos.udg.mx, Ramírez-Jirano, Luis Javier4 (AUTHOR) luis.ramirezj@imss.gob.mx
Publikováno v:
International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9476. 11p.
Autor:
Bauché D; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA david.bauche@merck.com., Mauze S; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA., Kochel C; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA., Grein J; Molecular Discovery, Merck & Co. Inc, South San Francisco, California, USA., Sawant A; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA., Zybina Y; Molecular Discovery, Merck & Co. Inc, South San Francisco, California, USA., Blumenschein W; Molecular Discovery, Merck & Co. Inc, South San Francisco, California, USA., Yang P; Anatomic Pathology, Merck & Co. Inc, South San Francisco, California, USA., Annamalai L; Anatomic Pathology, Merck & Co. Inc, South San Francisco, California, USA., Yearley JH; Anatomic Pathology, Merck & Co. Inc, South San Francisco, California, USA., Punnonen J; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA., Bowman EP; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA., Chackerian A; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA., Laface D; Discovery Oncology, Merck & Co. Inc, South San Francisco, California, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Oct; Vol. 8 (2).
Publikováno v:
Journal of Allergy and Clinical Immunology. 100:792-801
The relative contribution of IL-4 and IL-13 to the regulation of IgE synthesis has remained relatively poorly characterized, partially because of lack of suitable animal models. We have studied the roles of IL-4 and IL-13 in human IgE synthesis induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98376e670ede4d07a7f8a3b114f15c17
https://doi.org/10.1016/s0091-6749(97)70276-8
https://doi.org/10.1016/s0091-6749(97)70276-8
Autor:
Kurata, Hiroyuki1 (AUTHOR) kurata@bio.kyutech.ac.jp, Harun-Or-Roshid, Md.1 (AUTHOR), Tsukiyama, Sho1 (AUTHOR), Maeda, Kazuhiro1 (AUTHOR)
Publikováno v:
PLoS ONE. 8/22/2024, Vol. 19 Issue 8, p1-24. 24p.
Autor:
Idowu, Modoluwamu1 (AUTHOR), Taiwo, Godstime1 (AUTHOR), Sidney, Taylor1 (AUTHOR), Treon, Emily1 (AUTHOR), Leal, Yarahy1 (AUTHOR), Ologunagba, Deborah1 (AUTHOR), Eichie, Francisca1 (AUTHOR), Pech-Cervantes, Andres2 (AUTHOR), Ogunade, Ibukun M.1 (AUTHOR) Ibukun.ogunade@mail.wvu.edu
Publikováno v:
PLoS ONE. 7/3/2024, Vol. 19 Issue 7, p1-15. 15p.